The Diagnosis Performance of the TCM Syndromes of Irritable Bowel Syndrome by Gastroenterologists Based on Modified Simple Criteria Compared to TCM Practitioners: A Prospective, Multicenter Preliminary Study

الملخص EN

Purpose.

Traditional Chinese medicine (TCM) including Chinese patent medicine has been widely used to treat irritable bowel syndrome (IBS).

Syndrome differentiation is the essence of TCM.

However, the diagnostic ability of gastroenterologists to detect TCM syndromes in IBS in China remains unknown.

The aim of this study was to investigate the ability of gastroenterologists to diagnose the TCM syndromes of IBS based on modified simple criteria compared with TCM practitioners.

Methods.

Patients meeting the Rome III criteria for IBS-D or IBS-C were recruited from six tertiary referral centers between January 2016 and December 2017.

After learning the diagnosis criteria of the TCM syndromes in IBS, gastroenterologists first diagnosed the syndromes of the enrolled patients.

Subsequently, the patients were diagnosed by TCM practitioners.

The rate of agreement between the gastroenterologists and TCM practitioners was analyzed.

In addition, demographic data and the distribution of TCM syndrome types in IBS were also analyzed.

Results.

A total of 178 patients (93 males and 85 females), including 131 patients with IBS-D and 47 patients with IBS-C, were enrolled in this study.

The rate of agreement of the syndrome diagnosis between the gastroenterologists and TCM practitioners was 84.3%.

The diagnosis consistency rates among IBS-D patients and IBS-C patients were 87.0% and 76.5%, respectively.

The most common TCM syndrome type in IBS-D patients was liver depression and spleen deficiency syndrome (27.5%), followed by spleen-yang deficiency syndrome (19.8%).

Dryness and heat in intestine syndrome was the most common TCM syndrome in IBS-C patients (57.4%).

Conclusions.

Gastroenterologists had good diagnostic agreement with TCM practitioners for diagnosing TCM syndrome types in IBS after learning the diagnostic criteria.

This knowledge can aid gastroenterologists in selecting suitable Chinese patent medicine to treat IBS.